About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Appendix 4E and 2016 Annual Financial Report
February 28, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan
Next Post
Phosphagenics Full Year Financial Results
Related Posts
Avecho’s Phase III Clinical Trial for Insomnia Commences
March 26, 2024
March 26, 2024
Phosphagenics Signs a Multinational License for TPM® in Personal Care Products
December 4, 2017
2017 Annual Report
March 28, 2018